Granahan Investment Management - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$10,519,884
+23.9%
576,748
+40.5%
0.32%
+23.1%
Q4 2022$8,488,726
-5.5%
410,480
+19.6%
0.26%
-11.3%
Q3 2022$8,982,000
+41.6%
343,335
+37.1%
0.29%
+35.0%
Q2 2022$6,345,000
-11.1%
250,385
+10.8%
0.22%
+22.6%
Q1 2022$7,134,000
+28.3%
226,050
+64.5%
0.18%
+55.3%
Q4 2021$5,560,000
+52.1%
137,387
+31.0%
0.11%
+65.2%
Q3 2021$3,656,000104,8480.07%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q4 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$29,404,28419.15%
Decheng Capital Management III (Cayman), LLC 869,790$15,864,9706.40%
Octagon Capital Advisors LP 2,172,000$39,617,2805.70%
Boxer Capital, LLC 1,432,200$26,1231.28%
PFM Health Sciences, LP 1,559,947$28,453,4331.26%
SECTORAL ASSET MANAGEMENT INC 293,646$5,356,1031.03%
DAFNA Capital Management LLC 175,217$3,195,9580.96%
Ikarian Capital, LLC 230,000$4,195,2000.95%
Tejara Capital Ltd 50,000$912,0000.47%
Capital Impact Advisors, LLC 20,501$373,9380.46%
View complete list of ARCUS BIOSCIENCES INC shareholders